This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Trials.ai, Inc., Zs Associates, Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Kim Marie Walpole: Innovator in Clinical Trial Methodologies
Introduction
Kim Marie Walpole is a prominent inventor based in San Diego, California. She has made significant contributions to the field of clinical trials through her innovative approaches that leverage machine learning. With a total of two patents to her name, Walpole is recognized for her expertise in enhancing the planning, execution, and reporting of clinical trials.
Latest Patents
Walpole's latest patents focus on intelligent planning, execution, and reporting of clinical trials. These patents disclose machine learning-based methods that incorporate a patient burden index. One aspect of her invention involves a method for determining a patient burden index, which includes parsing a protocol for a clinical trial. The method further entails providing factor data for each of a plurality of patients and calculating a patient burden index for each patient based on the parsed protocol and the provided factor data.
Career Highlights
Throughout her career, Walpole has worked with notable companies such as Trials.ai, Inc. and ZS Associates, Inc. Her work has been instrumental in advancing methodologies that improve the efficiency and effectiveness of clinical trials.
Collaborations
Walpole has collaborated with several professionals in her field, including Michael Joseph Nicoletti and Joshua Michael Stanley. These collaborations have contributed to her innovative approaches and the successful development of her patents.
Conclusion
Kim Marie Walpole is a trailblazer in the realm of clinical trial methodologies, with her innovative patents paving the way for more efficient clinical research. Her contributions continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile